- Home
- SVT vs ACXP Comparison
SVT vs ACXP Comparison
Compare SVT & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SVT
- ACXP
- Stock Information
- Founded
- SVT 1959
- ACXP 2017
- Country
- SVT United States
- ACXP United States
- Employees
- SVT N/A
- ACXP N/A
- Industry
- SVT Industrial Machinery/Components
- ACXP Biotechnology: Pharmaceutical Preparations
- Sector
- SVT Consumer Discretionary
- ACXP Health Care
- Exchange
- SVT Nasdaq
- ACXP Nasdaq
- Market Cap
- SVT 27.1M
- ACXP 31.4M
- IPO Year
- SVT N/A
- ACXP 2021
- Fundamental
- Price
- SVT $11.10
- ACXP $0.81
- Analyst Decision
- SVT
- ACXP Strong Buy
- Analyst Count
- SVT 0
- ACXP 1
- Target Price
- SVT N/A
- ACXP $12.00
- AVG Volume (30 Days)
- SVT 1.1K
- ACXP 479.2K
- Earning Date
- SVT 03-21-2025
- ACXP 03-14-2025
- Dividend Yield
- SVT N/A
- ACXP N/A
- EPS Growth
- SVT N/A
- ACXP N/A
- EPS
- SVT 0.05
- ACXP N/A
- Revenue
- SVT $47,487,000.00
- ACXP N/A
- Revenue This Year
- SVT N/A
- ACXP N/A
- Revenue Next Year
- SVT N/A
- ACXP N/A
- P/E Ratio
- SVT $235.55
- ACXP N/A
- Revenue Growth
- SVT 19.50
- ACXP N/A
- 52 Week Low
- SVT $10.16
- ACXP $0.68
- 52 Week High
- SVT $13.85
- ACXP $3.35
- Technical
- Relative Strength Index (RSI)
- SVT 54.17
- ACXP 45.19
- Support Level
- SVT $10.39
- ACXP $0.70
- Resistance Level
- SVT $11.15
- ACXP $0.87
- Average True Range (ATR)
- SVT 0.31
- ACXP 0.06
- MACD
- SVT 0.02
- ACXP 0.01
- Stochastic Oscillator
- SVT 88.35
- ACXP 34.83
About SVT Servotronics Inc.
Servotronics Inc is a U.S based company that designs, manufactures, and markets servo valves, including torque motor, hydraulic, and pneumatic valves. The company has single reportable segment which is aerospace Its products are marketed and sold throughout the United States and in select foreign markets. These products are sold to commercial aviation manufacturers, government prime contractors, government subcontractors, and end-users.
About ACXP Acurx Pharmaceuticals Inc.
Acurx Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing a new class of antibiotics for infections caused by bacteria listed as priority pathogens by the World Health Organization, Centers for Disease Control and Prevention and Food and Drug Administration.